|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Capitalization1 |
18 446 | 18 038 | 18 092 | 17 028 | 17 028 | - |
Entreprise Value (EV)1 |
20 397 | 12 177 | 18 894 | 18 015 | 17 992 | 17 584 |
P/E ratio |
22,2x | 49,5x | 37,5x | 27,8x | 21,1x | 18,8x |
Yield |
8,90% | 7,95% | 2,10% | 2,13% | 2,39% | 2,62% |
Capitalization / Revenue |
1,27x | 1,95x | 1,95x | 2,00x | 1,89x | 1,82x |
EV / Revenue |
1,40x | 1,32x | 2,04x | 2,11x | 2,00x | 1,88x |
EV / EBITDA |
9,57x | 11,7x | 14,1x | 12,9x | 11,5x | 10,3x |
Price to Book |
3,15x | 1,71x | 3,04x | 2,73x | 2,66x | 2,57x |
Nbr of stocks (in thousands) |
224 552 | 227 750 | 199 600 | 189 706 | 189 706 | - |
Reference price (EUR) |
82,1 | 79,2 | 90,6 | 89,8 | 89,8 | 89,8 |
Last update |
03/08/2018 | 02/13/2019 | 02/12/2020 | 01/16/2021 | 01/16/2021 | 01/16/2021 |
1 EUR in Million Estimates
|
|
Income Statement Evolution | |
|
|
Annual Income Statement Data |
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Net sales1 |
14 575 | 9 256 | 9 276 | 8 528 | 8 987 | 9 348 |
EBITDA1 |
2 132 | 1 037 | 1 341 | 1 401 | 1 571 | 1 701 |
Operating profit (EBIT)1 |
1 525 | 798 | 991 | 1 069 | 1 236 | 1 356 |
Operating Margin |
10,5% | 8,62% | 10,7% | 12,5% | 13,8% | 14,5% |
Pre-Tax Profit (EBT)1 |
1 324 | 573 | 785 | 907 | 1 174 | 1 308 |
Net income1 |
832 | 410 | 539 | 617 | 782 | 861 |
Net margin |
5,71% | 4,43% | 5,81% | 7,23% | 8,70% | 9,21% |
EPS2 |
3,70 | 1,60 | 2,42 | 3,23 | 4,25 | 4,79 |
Dividend per Share2 |
7,31 | 6,30 | 1,90 | 1,91 | 2,15 | 2,35 |
Last update |
03/08/2018 | 02/13/2019 | 02/12/2020 | 01/16/2021 | 01/16/2021 | 01/16/2021 |
1 EUR in Million 2 EUR Estimates
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Net Debt1 |
1 951 | - | 802 | 987 | 964 | 556 |
Net Cash position1 |
- | 5 861 | - | - | - | - |
Leverage (Debt / EBITDA) |
0,92x | -5,65x | 0,60x | 0,70x | 0,61x | 0,33x |
Free Cash Flow1 |
356 | 2,00 | -181 | 775 | 893 | 997 |
ROE (Net Profit / Equities) |
13,4% | 4,63% | 7,26% | 10,6% | 13,0% | 14,0% |
Shareholders' equity1 |
6 209 | 8 850 | 7 425 | 5 837 | 6 040 | 6 158 |
ROA (Net Profit / Asset) |
5,14% | 2,35% | 4,16% | 5,45% | 6,58% | 7,06% |
Assets1 |
16 187 | 17 481 | 12 972 | 11 308 | 11 891 | 12 190 |
Book Value Per Share2 |
26,1 | 46,4 | 29,8 | 32,9 | 33,7 | 35,0 |
Cash Flow per Share2 |
4,33 | 0,64 | 0,15 | 4,85 | 5,82 | 6,50 |
Capex1 |
613 | 160 | 214 | 218 | 236 | 244 |
Capex / Sales |
4,21% | 1,73% | 2,31% | 2,56% | 2,63% | 2,61% |
Last update |
03/08/2018 | 02/13/2019 | 02/12/2020 | 01/14/2021 | 01/14/2021 | 01/14/2021 |
1 EUR in Million 2 EUR Estimates
|
|
|
| Financial data source © 2021 S&P Global Market Intelligence
|
|
|
Akzo Nobel targets rival-beating growth |
Capitalization (EUR) 17 028 016 394 Capitalization (USD) 20 587 615 033 Net sales (EUR) 9 276 000 000 Net sales (USD) 11 201 697 600 Number of employees 32 400 Sales / Employee (EUR) 286 296 Sales / Employee (USD) 345 731 Free-Float capitalization (EUR) 17 020 521 317 Free-Float capitalization (USD) 20 578 553 159 Avg. Exchange 20 sessions (EUR) 41 880 418 Avg. Exchange 20 sessions (USD) 50 574 793 Average Daily Capital Traded 0,25%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Evolution Valeur d'Entreprise / EBITDA
|